EA Mohamed, NSM Ismail, M Hagras… - Future Journal of …, 2021 - Springer
Background The heterocyclic compounds particularly pyridine displayed clinical and biological implementation. Pyridine scaffolds have been detected in most relevant drug …
Heterocyclic compounds play a critical role in medicinal chemistry, and many available drugs contain heterocyclic rings. A six-membered heterocyclic compound, pyridine, showed …
K Mezgebe, E Mulugeta - RSC advances, 2022 - pubs.rsc.org
Nowadays, there is significant interest in the synthesis of heterocycle-incorporated azo dye derivatives as potential scaffolds in the pharmaceutical sector. The pharmaceutical or drug …
S Prakash, G Somiya, N Elavarasan… - Journal of Molecular …, 2021 - Elsevier
The present work established the synthesis of novel azo incorporated heterocyclic bioactive compounds (4a-4d) via diazo-coupling reaction between the 2-amino benzothiazole and …
O Ebenezer, MA Jordaan, G Carena, T Bono… - International Journal of …, 2022 - mdpi.com
Heterocyclic compounds are a class of compounds of natural origin with favorable properties and hence have major pharmaceutical significance. They have an exceptional …
The incidence of cancer is increasing worldwide, affecting a vast majority of the human population, therefore, new different anticancer agents are being developed now and their …
PB Miniyar, PR Murumkar, PS Patil… - Mini reviews in …, 2013 - ingentaconnect.com
Pyrazine is one of the important class of heterocyclic compounds that can be obtained naturally or synthesized chemically. Pyrazine ring has got importance in exhibiting various …
M Alrooqi, S Khan, FA Alhumaydhi… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Pyridine derivatives are the most common and significant heterocyclic compounds, which show their fundamental characteristics to various pharmaceutical agents and natural …
Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as …